A carregar...
Scavenging Effects of Dexrazoxane on Free Radicals
Dexrazoxane (ICRF-187) has been clinically used to reduce doxorubicin-induced cardiotoxicity for more than 20 years. It has been proposed that dexrazoxane may act through its rings-opened hydrolysis product ADR-925, which can either remove iron from the iron-doxorubicin complex or bind to free iron,...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
the Society for Free Radical Research Japan
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2966934/ https://ncbi.nlm.nih.gov/pubmed/21103033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.10-64 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|